ConductScience.org, home

Paper33487592

Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.

Song S and 23 others. Gut, 2021. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Papers, record 33487592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33487592

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
PubMed
Journal
Gut
PubMed
Year
2021
PubMed
Publication types
Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
3.02
iCite
Revised in PubMed
2022-12-07
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Song SShumeihttps://orcid.org/0000-0002-8128-6287
2Chen QQiongronghttps://orcid.org/0000-0002-6613-535X
3Li YYuan
4Lei GGuang
5Scott AAiling
6Huo LLongfei
7Li CYCordelia Y
8Estrella JSJeannelyn Santiano
9Correa AArlene
10Pizzi MPMelissa Pool
11Ma LLang
12Jin JJiankang
13Liu BBin
14Wang YYing
15Xiao LLianchun
16Hofstetter WLWayne L
17Lee JHJeffrey H
18Weston BBrian
19Bhutani MManoop
20Shanbhag NNamita

Source PubMed

See all 24 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
Esophageal NeoplasmsMajor topic
GossypolMajor topic
Neoplastic Stem CellsMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
Stomach NeoplasmsMajor topic
Animals
Apoptosis
Cell Line, Tumor
Disease Models, Animal
Docetaxel
Female
Humans
Male
Mice
Middle Aged
Pilot Projects

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA160433NCI NIH HHSUnited StatesR01CA160433PubMedNIH RePORTER
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMedNIH RePORTER
R21 CA129906NCI NIH HHSUnited StatesR21CA129906PubMedNIH RePORTER
R21 CA127672NCI NIH HHSUnited StatesR21CA127672PubMedNIH RePORTER
R01 CA172741NCI NIH HHSUnited StatesR01CA172741PubMedNIH RePORTER
R01 CA138671NCI NIH HHSUnited StatesR01CA138671PubMedNIH RePORTER

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130563933YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer.Clin Cancer Res2019https://conductscience.org/library/papers/30563933PubMed
225099446Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.J Natl Compr Canc Netw2014https://conductscience.org/library/papers/25099446PubMed
329681456Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.Cell2018https://conductscience.org/library/papers/29681456PubMed
429115304Tumour heterogeneity and resistance to cancer therapies.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29115304PubMed
524210755ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.Mol Oncol2014https://conductscience.org/library/papers/24210755PubMed
618836097AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.Blood2009https://conductscience.org/library/papers/18836097PubMed
730850544Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30850544PubMed
830992437Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.Nat Commun2019https://conductscience.org/library/papers/30992437PubMed
928728163Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.Br J Cancer2017https://conductscience.org/library/papers/28728163PubMed
1025604264Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance.Cancer Res2015https://conductscience.org/library/papers/25604264PubMed
1128052061Integrated genomic characterization of oesophageal carcinoma.Nature2017https://conductscience.org/library/papers/28052061PubMed
1218292288Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.Blood2008https://conductscience.org/library/papers/18292288PubMed
1327654712Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer.Clin Cancer Res2016https://conductscience.org/library/papers/27654712PubMed
1427697982Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2016https://conductscience.org/library/papers/27697982PubMed
1528209166Intra-tumor heterogeneity from a cancer stem cell perspective.Mol Cancer2017https://conductscience.org/library/papers/28209166PubMed
1628397828EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.Nat Rev Clin Oncol2017https://conductscience.org/library/papers/28397828PubMed
1731182574Lineage tracing and targeting of IL17RB+ tuft cell-like human colorectal cancer stem cells.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31182574PubMed
1826822577Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.Nat Rev Cancer2016https://conductscience.org/library/papers/26822577PubMed
1923536563Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.Cancer Res2013https://conductscience.org/library/papers/23536563PubMed
2025711863YAP and the drug resistance highway.Nat Genet2015https://conductscience.org/library/papers/25711863PubMed

See all 55 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42788341Reprogramming of cell death in gastric cancer: From molecular mechanisms to therapeutic potential (Review).Int J Mol Med2026https://conductscience.org/library/papers/42788341PubMed
42425097Molecular mechanisms, current therapeutics, and emerging strategies in esophageal cancer: A comprehensive review.Chin Med J (Engl)2026https://conductscience.org/library/papers/42425097PubMed
42317336Overcoming chemoresistance in esophageal cancer with synergistic strategies.Front Immunol2026https://conductscience.org/library/papers/42317336PubMed
42065052Multidimensional Regulatory Network of YAP1 Driving Malignant Progression in Esophageal Cancer: Molecular Mechanisms and Targeted Therapy: A Review.Oncol Res2026https://conductscience.org/library/papers/42065052PubMed
41596764BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting.Int J Mol Sci2026https://conductscience.org/library/papers/41596764PubMed
40970582
A Critical Review on BH3 Mimetic Drugs and the Treatment of Cancer-Associated Thrombosis (CAT): A Proposed Design for a Drug Delivery System Capable of Simultaneously Targeting Tumor Cells and Activated Platelets.
Cancer Med2025https://conductscience.org/library/papers/40970582PubMed
40678726Potential value and cardiovascular risks of programmed cell death in cancer treatment.Front Pharmacol2025https://conductscience.org/library/papers/40678726PubMed
40576138Decoding the role of cancer stem cells in digestive tract tumors: Mechanisms and therapeutic implications (Review).Int J Oncol2025https://conductscience.org/library/papers/40576138PubMed
40325218Clofoctol impairs the stemness of gastric cancer and induces TNF-mediated necroptosis by directly binding to RanBP2.Cell Mol Life Sci2025https://conductscience.org/library/papers/40325218PubMed
40148719AT101 Suppresses Gastrointestinal Stromal Tumor Growth and Promotes Apoptosis via YAP/TAZ-CCND1 and FBXW7-MCL1 Axes.Ann Surg Oncol2025https://conductscience.org/library/papers/40148719PubMed
40075071Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer.Cell Death Dis2025https://conductscience.org/library/papers/40075071PubMed
39796683Metabolic-Modulating Effects of Radiation: Undetectable Yet Deadly-A Review on Radiotherapy.Cancers (Basel)2024https://conductscience.org/library/papers/39796683PubMed
39735667Combination of fruquintinib with venetoclax for the treatment of colorectal cancer.Oncol Res2025https://conductscience.org/library/papers/39735667PubMed
39621144Circ_0000972 Inhibits Hepatocellular Carcinoma Cell Stemness by Targeting miR-96-5p/PFN1.Biochem Genet2025https://conductscience.org/library/papers/39621144PubMed
39557657YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway.J Gastroenterol2025https://conductscience.org/library/papers/39557657PubMed
39524138Gastrokine 1 transferred by gastric cancer exosomes inhibits growth and invasion of gastric cancer cells in vitro and in vivo.J Cell Commun Signal2024https://conductscience.org/library/papers/39524138PubMed
39372401Lactate's impact on immune cells in sepsis: unraveling the complex interplay.Front Immunol2024https://conductscience.org/library/papers/39372401PubMed
38653754SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38653754PubMed
38505381Circular RNA hsa_circ_0051246 acts as a microRNA-375 sponge to promote the progression of gastric cancer stem cells via YAP1.PeerJ2023https://conductscience.org/library/papers/38505381PubMed
38397398The Role of Methionine Restriction in Gastric Cancer: A Summary of Mechanisms and a Discussion on Tumor Heterogeneity.Biomolecules2024https://conductscience.org/library/papers/38397398PubMed

See all 38 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33487592

GET https://conductscience.org/api/papers/v1/33487592/authors?page=2